Diet soda linked to increase in glucagon-like peptide 1 levels

March 22, 2012
Diet soda linked to increase in glucagon-like peptide 1 levels
Drinking a diet soda before a glucose load is associated with increased glucagon-like peptide 1 secretion in individuals with type 1 diabetes and healthy controls, but not in those with type 2 diabetes, according to research published online March 12 in Diabetes Care.

(HealthDay) -- Drinking a diet soda before a glucose load is associated with increased glucagon-like peptide 1 (GLP-1) secretion in individuals with type 1 diabetes and healthy controls, but not in those with type 2 diabetes, according to research published online March 12 in Diabetes Care.

Rebecca J. Brown, M.D., M.H.S.C., of the National Institute of Diabetes and Digestive and Kidney Diseases in Bethesda, Md., and colleagues conducted a randomized, crossover study involving nine individuals with type 1 diabetes, 10 with type 2 diabetes, and 25 healthy controls, aged 12 to 25 years. Participants drank either a cola-flavored, caffeine-free or carbonated water, followed by a 75-gram glucose load. They then underwent glucose, C-peptide, GLP-1, glucose-dependent insulinotropic peptide, and peptide Tyr-Tyr measurements for 180 minutes.

Compared with carbonated water, the researchers found that, after ingestion of diet soda, the GLP-1 area under the curve was 34 percent higher in healthy subjects and 43 percent higher in individuals with (P = 0.029 and 0.020, respectively), but was unaffected in subjects with type 2 diabetes. None of the other gut hormone measures were significantly statistically different between the groups after ingestion of diet soda or carbonated water.

"It is unknown whether changes in endogenous GLP-1 secretion as observed in the current study have any clinically relevant consequences, such as increased satiety and slowed gastric emptying," the authors write.

Explore further: Research reveals hormone action that could lead to treatments for type 2 diabetes

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Research reveals hormone action that could lead to treatments for type 2 diabetes

September 30, 2011
(Medical Xpress) -- Researchers at the University of Cincinnati have discovered that the immediate improvement in blood sugar (blood glucose) for those with type 2 diabetes who undergo gastric bypass surgery is related to ...

Gut hormone leads to weight loss in overweight or obese patients

January 10, 2012
Giving overweight or obese patients a gut hormone that suppresses appetite leads to clinically beneficial weight loss as well as reduced blood pressure and cholesterol levels, finds a study published in the British Medical ...

Bile acids may hold clue to treat heart disease

December 6, 2011
Heart disease is a major cause of death in industrialised countries, and is strongly associated with obesity and diabetes. Many scientists believe that what links these conditions is a chronic, low-grade inflammation. The ...

Improving psoriasis with GLP-1 analogue therapy

December 13, 2011
(Medical Xpress) -- UCD clinician scientists and researchers from NUI Maynooth and Trinity College led by Conway Fellow, Professor Donal O’Shea have reported an improvement in the severity of psoriasis in patients following ...

Recommended for you

Diabetes can be tracked with our Google searches

July 26, 2017
The emergence of Type 2 Diabetes could be more effectively monitored using our Google searches—helping public health officials keep track of the disease and halt its spread—according to research by the University of Warwick.

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.